Szot, Christopher <br/><br/>
Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug release.  [electronic resource] 

 -  The Journal of clinical investigation  07 2018 
 - 2927-2943 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI120481  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacokinetics<br/>Biomarkers, Tumor--antagonists & inhibitors<br/>Brentuximab Vedotin<br/>Cell Line, Tumor<br/>Female<br/>Humans<br/>Immunoconjugates--pharmacokinetics<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Mice, Nude<br/>Mice, SCID<br/>Microfilament Proteins<br/>Neoplasm Proteins--antagonists & inhibitors<br/>Neoplasms--drug therapy<br/>Receptors, Cell Surface--antagonists & inhibitors<br/>Receptors, Peptide--antagonists & inhibitors<br/>Stromal Cells--drug effects<br/>Tumor Microenvironment--drug effects<br/>Xenograft Model Antitumor Assays